221025-37-2Relevant academic research and scientific papers
De novo synthesis of imidazoles by visible-light-induced photocatalytic aerobic oxidation/[3+2] cycloaddition/aromatization cascade
Deng, Qiao-Hui,Zou, You-Quan,Lu, Liang-Qiu,Tang, Zi-Long,Chen, Jia-Rong,Xiao, Wen-Jing
supporting information, p. 2432 - 2435 (2014/10/15)
A visible-light-induced photocatalytic aerobic oxidation/[3+2] cycloaddition/aromatization cascade between secondary amines and isocyanides has been successfully developed. The reaction provides a general and efficient access to diversely substituted imidazoles and imidazo[1,5-a]quinoxalin-4(5 H)-ones in good yields under mild conditions.
Reaction of quinoxalin-2-ones with TosMIC reagent: Synthesis of imidazo[1,5-a]quinoxalin-4-ones
Chen, Ping,Barrish, Joel C.,Iwanowicz, Edwin,Lin, James,Bednarz, Mark S.,Chen, Bang-Chi
, p. 4293 - 4295 (2007/10/03)
Imidazo[1,5-a]quinoxalin-4-ones were prepared in four steps starting from 1,2-phenylenediamines using a new strategy for the construction of the ring system. A key step in this new method involves the reaction of quinoxalin-2-ones with TosMIC (tosylmethyl isocyanide).
Imidazoquinoxaline protein tyrosine kinase inhibitors
-
, (2008/06/13)
Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.
Imidazoquinoxaline protein tyrosine kinase inhibitors
-
, (2008/06/13)
Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.
